Draoua H Y, Tsao Lawrence, Mancini Donna M, Addonizio Linda J, Bhagat Govind, Alobeid Bachir
Department of Pathology, Columbia University, New York, NY, USA.
Br J Haematol. 2004 Nov;127(4):429-32. doi: 10.1111/j.1365-2141.2004.05212.x.
Post-transplantation lymphoproliferative disorders (PTLDs) are a well-recognized and potentially life-threatening complication of solid organ transplantation. While the vast majority of PTLDs are B-cell lymphoproliferations, T-cell PTLDs are rarely seen. Among 898 patients receiving cardiac transplants between 1990 and 2003, 34 patients (3.8%) developed PTLDs with two (0.2%) T-cell PTLDs, 31 (3.5%) B-cell PTLDs and one (0.1%) natural killer cell PTLD. An additional three cases of T-cell PTLD were identified among all cardiac transplant patients followed at our institution. These T-cell PTLDs comprised a heterogeneous group of Epstein-Barr virus negative lymphoproliferations that developed late after transplantation and followed an aggressive course.
移植后淋巴细胞增生性疾病(PTLD)是实体器官移植中一种公认的、可能危及生命的并发症。虽然绝大多数PTLD是B细胞淋巴细胞增生,但T细胞PTLD很少见。在1990年至2003年间接受心脏移植的898例患者中,34例(3.8%)发生了PTLD,其中2例(0.2%)为T细胞PTLD,31例(3.5%)为B细胞PTLD,1例(0.1%)为自然杀伤细胞PTLD。在我们机构随访的所有心脏移植患者中又发现了3例T细胞PTLD。这些T细胞PTLD由一组异质性的爱泼斯坦-巴尔病毒阴性淋巴细胞增生组成,这些增生在移植后较晚发生,且病程进展迅速。